Key Points
- Heartflow CEO John Farquhar sold 38,900 shares at an average price of $49.57, generating approximately $1.93 million. The Rule 10b5-1 transaction reduced his direct holdings by 12.08% to 283,014 shares.
- Heartflow shares opened at $49.46, down 1.7%, but remain near their 52-week high of $54.32. The company recently reported revenue growth of 47.7% year over year and quarterly EPS that beat analyst expectations, despite continuing losses.
- Analyst sentiment remains generally positive, with a consensus rating of “Moderate Buy” and a $46.25 price target; several firms recently raised their targets, including Canaccord Genuity to $56.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John Farquhar sold 38,900 shares of the firm's stock in a transaction on Monday, October 12th. The shares were sold at an average price of $49.57, for a total transaction of $1,928,273.00. Following the completion of the transaction, the chief executive officer directly owned 283,014 shares of the company's stock, valued at approximately $14,029,003.98. This trade represents a 12.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John C.M. Farquhar also recently made the following trade(s):
- On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total transaction of $194,500.00.
- On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The stock was sold at an average price of $46.42, for a total transaction of $1,625,164.20.
- On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
- On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
- On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total value of $607,773.60.
- On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.
Heartflow Stock Down 1.7%
NASDAQ:HTFL opened at $49.46 on Thursday. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $54.32. The stock's 50-day simple moving average is $46.40 and its 200 day simple moving average is $34.99.
Heartflow (NASDAQ:HTFL - Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The firm had revenue of $64.08 million during the quarter. Heartflow's revenue was up 47.7% compared to the same quarter last year. On average, analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on HTFL shares. Benchmark reiterated a "buy" rating on shares of Heartflow in a research note on Friday, August 14th. Wall Street Zen raised shares of Heartflow from a "hold" rating to a "buy" rating in a research note on Saturday, October 3rd. Canaccord Genuity Group boosted their target price on shares of Heartflow from $45.00 to $56.00 and gave the stock a "buy" rating in a report on Tuesday, September 22nd. Wells Fargo & Company upped their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Friday, August 14th. Finally, Stifel Nicolaus increased their price target on shares of Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $46.25.
Get Our Latest Stock Report on HTFL
Institutional Investors Weigh In On Heartflow
A number of large investors have recently added to or reduced their stakes in the business. XXEC Inc. acquired a new stake in Heartflow during the 2nd quarter valued at $2,524,764,000. BlackRock Inc. bought a new position in Heartflow during the second quarter worth $152,502,000. Bamco Inc. NY acquired a new position in shares of Heartflow in the second quarter valued at $94,625,000. Jupiter Topco LLC acquired a new position in shares of Heartflow in the second quarter valued at $70,983,000. Finally, Janus Henderson Group PLC increased its holdings in shares of Heartflow by 152.0% in the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock valued at $53,063,000 after purchasing an additional 1,315,416 shares during the last quarter.
Heartflow Company Profile
(
Get Free Report)
HeartFlow, Inc is a medical technology company focused on improving the diagnosis and management of coronary artery disease. The company develops software and clinical tools that use artificial intelligence, advanced image analysis and data from coronary computed tomography angiography (CCTA) scans to provide noninvasive assessments of blood flow and potential blockages in the heart.
Its principal product is the HeartFlow Analysis, which creates a personalized, three-dimensional model of a patient's coronary arteries and can estimate the impact of blockages on blood flow.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
